BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP

Genes and Development

Volumn 20, Issue 13, 2006, Pages 1721-1726

  Yu, Xiaochun ^a   Fu, Shuang ^b   Lai, Maoyi ^a   Baer, Richard ^b   Chen, Junjie ^a  

^a MAYO CLINIC   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

BRCA1; BRCT domain; CtIP; DNA damage; Phosphorylation; Ubiquitination

Indexed keywords

BRCA1 PROTEIN; CELL CYCLE PROTEIN; PROTEIN CTIP; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CYCLE G2 PHASE; CHROMATIN; DNA DAMAGE; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

BRCA1 PROTEIN; CARRIER PROTEINS; CATALYSIS; CELL CYCLE; CELL LINE; CHROMATIN; DNA DAMAGE; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SERINE; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 33745614048     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1431006     Document Type: Article

References (33)

1. Baer, R. and Ludwig, T. 2002. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr. Opin. Genet. Dev. 12: 86-91.
2. Brzovic, P.S., Rajagopal, P., Hoyt, D.W., King, M.C., and Klevit, R.E. 2001. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8: 833-837.
3. Brzovic, P.S., Keeffe, J.R., Nishikawa, H., Miyamoto, K., Fox III, D., Fukuda, M., Ohta, T., and Klevit, R. 2003. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl. Acad. Sci. 100: 5646-5651.
4. Chen, A., Kleiman, F.E., Manley, J.L., Ouchi, T., and Pan, Z.Q. 2002. Autoubiquitination of the BRCA1·BARD1 RING ubiquitin ligase. J. Biol. Chem. 277: 22085-22092.
5. Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M.S., Timmers, C., Hejna, J., Grompe, M., and D'Andrea, A.D. 2001. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7: 249-262.
6. Germani, A., Prabel, A., Mourah, S., Podgorniak, M.P., Di Carlo, A., Ehrlich, R., Gisselbrecht, S., Varin-Blank, N., Calvo, F., and Bruzzoni-Giovanelli, H. 2003. SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene 22: 8845-8851.
7. Glover, J.N., Williams, R.S., and Lee, M.S. 2004. Interactions between BRCT repeats and phosphoproteins: Tangled up in two. Trends Biochem. Sci. 29: 579-585.
8. Greenberg, R.A., Sobhian, B., Pathania, S., Cantor, S.B., Nakatani, Y., and Livingston, D.M. 2006. Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes & Dev. 20: 34-46.
9. Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., and Ohta, T. 2001. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancerderived mutation. J. Biol. Chem. 276: 14537-14540.
10. Kleiman, F.E., Wu-Baer, F., Fonseca, D., Kaneko, S., Baer, R., and Manley, J.L. 2005. BRCA1/BARD1 inhibition of mRNA 3′ processing involves targeted degradation of RNA polymerase II. Genes & Dev. 19: 1227-1237.
11. Lorick, K.L., Jensen, J.P., Fang, S., Ong, A.M., Hatakeyama, S., and Weissman, A.M. 1999. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. 96: 11364-11369.
12. Manke, I.A., Lowery, D.M., Nguyen, A., and Yaffe, M.B. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302: 636-639.
13. Montes de Oca, R., Andreassen, P.R., Margossian, S.P., Gregory, R.C., Taniguchi, T., Wang, X., Houghtaling, S., Grompe, M., and D'Andrea, A.D. 2005. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood 105: 1003-1009.
14. Morris, J.R. and Solomon, E. 2004. BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum. Mol. Genet. 13: 807-817.
15. Nguyen, H.G., Chinnappan, D., Urano, T., and Ravid, K. 2005. Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: Identification of an aneuploidy-promoting property. Mol. Cell. Biol. 25: 4977-4992.
16. Rodriguez, M., Yu, X., Chen, J., and Songyang, Z. 2003. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. J. Biol. Chem. 278: 52914-52918.
17. Ruffner, H., Joazeiro, C.A., Hemmati, D., Hunter, T., and Verma, I.M. 2001. Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. 98: 5134-5139.
18. Sato, K., Hayami, R., Wu, W., Nishikawa, T., Nishikawa, H., Okuda, Y., Ogata, H., Fukuda, M., and Ohta, T. 2004. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase. J. Biol. Chem. 279: 30919-30922.
19. Scully, R., Ganesan, S., Vlasakova, K., Chen, J., Socolovsky, M., and Livingston, D.M. 1999. Genetic analysis of BRCA1 function in a defined tumor cell line. Mol. Cell 4: 1093-1099.
20. Starita, L.M., Machida, Y., Sankaran, S., Elias, J.E., Griffin, K., Schlegel, B.P., Gygi, S.P., and Parvin, J.D. 2004. BRCA1-dependent ubiquitination of γ-tubulin regulates centrosome number. Mol. Cell. Biol. 24: 8457-8466.
21. Starita, L.M., Horwitz, A.A., Keogh, M.C., Ishioka, C., Parvin, J.D., and Chiba, N. 2005. BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II. J. Biol. Chem. 280: 24498-24505.
22. Taniguchi, T., Garcia-Higuera, I., Andreassen, P.R., Gregory, R.C., Grompe, M., and D'Andrea, A.D. 2002. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100: 2414-2420.
23. Tomlinson, G.E., Chen, T.T., Stastny, V.A., Virmani, A.K., Spillman, M.A., Tonk, V., Blum, J.L., Schneider, N.R., Wistuba, I.I., Shay, J.W., et al. 1998. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 58: 3237-3242.
24. Varma, A.K., Brown, R.S., Birrane, G., and Ladias, J.A. 2005. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Biochemistry 44: 10941-10946.
25. Wang, X., Andreassen, P.R., and D'Andrea, A.D. 2004. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24: 5850-5862.
26. Ward, I.M. and Chen, J. 2001. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276: 47759-47762.
27. Wong, A.K., Ormonde, P.A., Pero, R., Chen, Y., Lian, L., Salada, G., Berry, S., Lawrence, Q., Dayananth, P., Ha, P., et al. 1998. Characterization of a carboxy-terminal BRCA1 interacting protein. Oncogene 17: 2279-2285.
28. Wu-Baer, F., Lagrazon, K., Yuan, W., and Baer, R. 2003. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J. Biol. Chem. 278: 34743-34746.
29. Xia, Y., Pao, G.M., Chen, H.W., Verma, I.M., and Hunter, T. 2003. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J. Biol. Chem. 278: 5255-5263.
30. Yu, X. and Baer, R. 2000. Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor. J. Biol. Chem. 275: 18541-18549.
31. Yu, X. and Chen, J. 2004. DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains. Mol. Cell. Biol. 24: 9478-9486.
32. Yu, X., Wu, L.C., Bowcock, A.M., Aronheim, A., and Baer, R. 1998. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273: 25388-25392.
33. Yu, X., Chini, C.C., He, M., Mer, G., and Chen, J. 2003. The BRCT domain is a phospho-protein binding domain. Science 302: 639-642.